Valsartan

Diovan, Valsacor, Valsartan · ATC code C09CA03

Brand names: Diovan, Valsacor, Valsaraxiro, Cardopan, Ceracard, Hixar, Limiten, Premium, Tamgard, Valcor, Valso, Valtensin, Viasart, Wansaar

Key facts
Active substance: Valsartan
ATC code: C09CA03
Authorisation: authorised nationally; no central EU authorisation
Information as of: 2026-10-27

Boxed warning

• When pregnancy is detected, discontinue valsartan as soon as possible. (5.1)
• Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1)

Key facts

Valsartan is an angiotensin II receptor blocker. It is used for hypertension, heart failure and left ventricular dysfunction after myocardial infarction.

What it is used for

Hypertension in adults and pediatric patients one year of age and older
Heart failure (NYHA class II-IV) in adults, to reduce the risk of hospitalization
Clinically stable adults with left ventricular failure or dysfunction after myocardial infarction, to reduce cardiovascular mortality

Dosing

Adult hypertension: start 80 mg or 160 mg once daily; range 80 mg to 320 mg once daily
Pediatric hypertension (1 to 16 years): start 1 mg/kg once daily (up to 40 mg), maximum 4 mg/kg (maximum 160 mg daily)
Heart failure: start 40 mg twice daily, uptitrate to 80 mg and 160 mg twice daily
Post-myocardial infarction: start 20 mg twice daily, target 160 mg twice daily
Tablets and oral suspension are not substitutable milligram-per-milligram

Contraindications

Known hypersensitivity to any component
Coadministration of aliskiren in patients with diabetes

Important warnings

Boxed warning: fetal toxicity; discontinue as soon as possible when pregnancy is detected
Hypotension, especially in volume- or salt-depleted patients (e.g. high-dose diuretics)
Impaired renal function may occur
Hyperkalemia

Side effects

Generally mild and transient; overall incidence similar to placebo
Viral infection (3%), fatigue (2%), abdominal pain (2%)
Most common reasons for discontinuation: headache and dizziness

Interactions

Other RAS blockers, potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes: increased serum potassium
NSAIDs including COX-2 inhibitors
Aliskiren contraindicated in patients with diabetes

Pregnancy and breastfeeding

Can cause fetal harm, especially in the second and third trimesters; discontinue as soon as possible when pregnancy is detected

Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

Patient information (US) →

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Austria

DiovanNovartis Pharma Gmbh · 1 register entry
ValsacorKrka, D.D., Novo Mesto · 1 register entry
Valsartan1a Pharma Gmbh, Actavis Group Ptc Ehf., Sandoz Gmbh, Stada Arzneimittel Gmbh · 4 register entries

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Germany

DiovanNovartis Pharma Gmbh · 3 register entries
ValsacorTad Pharma Gmbh · 1 register entry
ValsaraxiroMedical Valley Invest Ab · 1 register entry
Valsartan1 A Pharma Gmbh, Puren Pharma Gmbh & Co. Kg, Zentiva Pharma Gmbh, Basics Gmbh, Hennig Arzneimittel Gmbh & Co. Kg, Hexal Ag, Stadapharm Gmbh, Viatris Germany Gmbh, Aliud Pharma Gmbh · 10 register entries

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

CardopanSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 5 register entries
CeracardASET İLAÇ SAN. VE TİC. A.Ş. · 5 register entries
DiovanNOVARTİS SAĞLIK GIDA VE TARIM ÜRÜNLERİ SAN. VE TİC. A.Ş. · 5 register entries
HixarALİ RAİF İLAÇ SAN. A.Ş. · 6 register entries
LimitenNEUTEC İLAÇ SAN. TİC. A.Ş · 6 register entries
PremiumABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
TamgardFARMANOVA SAĞLIK HİZMETLERİ LTD. ŞTİ. · 1 register entry
ValcorİLKO İLAÇ SAN.VE TİC. A.Ş. · 3 register entries
ValsoNOBEL İLAÇ PAZARLAMA VE SAN. LTD. ŞTİ. · 6 register entries
ValtensinACTAVİS İLAÇLARI A.Ş. · 2 register entries
ViasartWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
WansaarHUMANİS SAĞLIK A.Ş. · 8 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

USA

DiovanNovartis Pharmaceuticals Corporation · 1 register entry

Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28

Brand names in 27 more European countries

Belgium: Diovane, Valsartan Eg, Valsartan Krka, Valsartan Sandoz
Bulgaria: Suvartar, Валдипин, Валсавил, Валсакор, Валтензин, Вапрес, Диован, Сартег
Croatia: Diovan, Val, Valnorm, Valsacor
Cyprus: Codaval, Diovan, Troval, Valsartan Jubilant, Valsartan Krka, Vapress
Czechia: Blessin, Diovan, Valsacor, Valsartan Krka, Valzap
Denmark: Diovan, Valhelen, Valsartan Jubilant, Valsartan Krka, Valsartan Teva
Estonia: Diovan, Valsacor, Valsartan Krka
Finland: Diovan, Valsarstad, Valsartan Actavis, Valsartan Krka, Valsartan Sandoz
France: Tareg, Valsartan Arrow Lab, Valsartan Biogaran, Valsartan Cristers, Valsartan Eg, Valsartan Evolugen, Valsartan Krka, Valsartan Sandoz, Valsartan Teva, Valsartan Viatris, Valsartan Zentiva, Valsartan Zydus
Greece: Avalsan, Diosartan, Diovan, Valperol, Valsaben, Valsareta, Valsart, Zakodian
Hungary: Diovan, Tensart, Valsacor, Valsartan Krka, Valsartan Sandoz, Valsartan Teva, Valsocard
Iceland: Diovan, Docartan, Primartan, Ramartan, Valpress, Valsartan Jubilant, Valsartan Krka
Ireland: Diovan, Valsartan Krka, Valsartan Rowa, Valsartan Teva, Valsartan Viatris, Valtan, Vatan
Italy: Alsartir, Pressloval, Rixil, Tareg, Valpression, Valsartan Almus, Valsartan Alter, Valsartan Doc Generici, Valsartan Eg, Valsartan Hcs, Valsartan Mylan Generics, Valsartan Pensa, Valsartan Sandoz, Valsartan Tecnigen, Valsartan Zentiva
Latvia: Diovan, Valsacor
Lithuania: Diovan, Suvartar, Valsacor, Valsartan Ingen Pharma, Valsartan Krka, Vanatex
Luxembourg: Diovane, Valsartan Eg
Malta: Diovan, Valsaben, Valsartan Jubilant, Valsartan Krka, Valsartan Macleods, Valtan, Vapress
Netherlands: Diovan, Exsartz, Vagrecor, Valsartan Aurobindo, Valsartan Cf, Valsartan Jubilant, Valsartan Krka, Valsartan Pch, Valsartan Sandoz, Valsartan Viatris, Valsartan Xiromed
Norway: Diovan, Valsartan Actavis, Valsartan Krka, Valsartan Sandoz
Poland: Aurovalsart, Avasart, Bespres, Diovan, Dipper-Mono, Tensart, Valsacor, Valsartan Medical Valley, Valzek, Vanatex, Walsartan Krka
Portugal: Diovan, Valsartan Alter, Valsartan Aurobindo, Valsartan Aurovitas, Valsartan Azevedos, Valsartan Baldacci, Valsartan Ciclum, Valsartan Coratenz, Valsartan Farmoz, Valsartan Generis, Valsartan Limeg, Valsartan Maxmind, Valsartan Mylan, Valsartan Pentafarma, Valsartan Tecnimede, Valsartan Tetrafarma, Valsartan Tolife
Romania: Diovan, Valsacor
Slovakia: Diovan, Valsacor, Valsartan Krka, Valsartan Teva, Valzap
Slovenia: Diovan, Valsacor
Spain: Diován, Kalpress, Presar, Vals, Valsartan Cardio Viatris, Valsartan Kern Pharma, Valsartan Tarbis, Valsartan Teva-Ratiopharm, Valsartan Viatris, Valsartán Almus, Valsartán Alter, Valsartán Aurovitas, Valsartán Cardio Stada, Valsartán Cinfa, Valsartán Combix, Valsartán Durban, Valsartán Farmalider, Valsartán Kern Pharma, Valsartán Krka, Valsartán Mabo, Valsartán Macleods, Valsartán Normon, Valsartán Pensa, Valsartán Pharmakern, Valsartán Sandoz, Valsartán Stada, Valsartán Stadafarma, Valsartán Sun, Valsartán Tad, Valsartán Tecnigen, Valsartán Teva-Ratiopharm
Sweden: Angiosan, Diovan, Valsartan Actavis, Valsartan Jubilant, Valsartan Krka, Valsartan Ratiopharm, Valsartan Sandoz, Valsartore, Vapress, Vilantal, Vivendal

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Related calculators

eGFR (CKD-EPI 2021)

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

U.S. Food and Drug Administration. Valsartan (Solco Healthcare US, LLC) – Prescribing Information, 2025-08-26. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26080940-bcd3-446d-9026-3ddfb58e281e
EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.